Proprietary screw for hip fracture surgery reduces implant failures and healthcare costs
The INTERTANâ„¢ Intertrochanteric Antegrade Nail, from Smith & Nephew, improves patient outcomes and saves up to US$2700 per patient, according to new studies.
New studies, published in Rheumatology and Orthopedic Medicine and Journal of Orthopaedic Surgery and Research respectively, indicate that a propriety intertrochanteric screw utilized in hip fracture surgery, reduced implant failures by 81% and revision surgery by 65%, saving time and up to US$2700 per patient. The INTERTANâ„¢ Intertrochanteric Antegrade Nail was developed by from Smith & Nephew (London, UK).
“Hip fractures and their sequelae in elderly patients can be debilitating, and potentially life threatening, and contribute a significant portion to overall health care expenditure. These new studies demonstrate that the Integrated Compression Screw used in the INTERTAN nail not only improved the clinical outcomes for these patients studied, but also reduced the cost to the overall health economic system by reducing the revision rates, compared to those that have been demonstrated in prior studies,” commented J. Tracy Watson, Orthopaedic Traumatologist (AZ, USA) and co-author for both papers.
The results were announced at the 34th Orthopaedic Trauma Association Annual Meeting (17—20 October, FL, USA) and reviewed data from 2631 patients across both studies.